Comprehensive Drug Discovery Expertise in Portishead

Charles River’s Portishead site, originally founded as KWS BioTest Ltd. in 2004 and acquired in 2018, operates with approximately 75 full-time employees, 65% of whom hold advanced degrees. The facility spans 22,500 square feet and includes specialized laboratories and two distinct vivaria dedicated to immunology and infectious disease research. The site provides integrated support for preclinical development, emphasizing precision and scientific rigor.

Laboratory Details

  • Approximately 22,500 square feet
  • In vivo rodent models
  • Two distinct vivaria: immunology unit and infection unit
  • Analytical laboratories
  • Tissue culture laboratories
3D molecular model of a blue protein complex with a small red ligand bound

Target Smarter: Translational Tools for Immune Reset in Autoimmune and Allergy Therapeutics
This webinar will explore how CAR-T, B cell-depleting therapies, and mast cell-targeted approaches are reshaping the future of treatment and, more importantly, how it will influence your drug discovery strategies. Whether you’re advancing a new candidate or exploring drug repurposing opportunities, this session delivers insights to help you stay ahead and drive the future of immunology drug discovery. Watch Replay

Service Areas and Study Types

Certifications

Charles River’s Portishead facility operates in compliance with the requirements of the following regulatory agencies or accredited organizations

  • GCLP
  • AAALAC

Humane Care Initiative

Charles River is a worldwide leader in the humane care of laboratory animals. We work hand-in-hand with the scientific community to understand how living conditions, handling procedures and stress play an important role in the quality and efficiency of research.

Contact an Expert